瑞舒伐他汀改善动脉硬化性脑梗死患者血脂与神经功能的临床研究
Efficacy of rosuvastatin on neurofunctional and blood lipid in patients with arteriosclerotic cerebral infarction
-
摘要: 目的:探讨瑞舒伐他汀对动脉硬化性脑梗死患者血脂与神经功能的影响及其临床意义。方法:将62例动脉硬化性脑梗死患者,按前瞻随机开放法分为观察组与对照组,各31例。根据不同病情,合理给予抗血小板聚集药物、清除氧自由基药物及活血化瘀药物;观察组在上述基础上加用瑞舒伐他钙汀片,比较2组治疗前及治疗后3、6、12个月血脂、神经功能、颈动脉内膜-中层厚度(IMT)及梗死灶面积。结果:与对照组比较,观察组患者治疗12个月后,胆固醇、三酰甘油、低密度脂蛋白均明显降低(P<0.01),高密度脂蛋白明显升高(P<0.01),IMT明显减小(P<0.01),神经功能得到明显改善(P< 0.01);治疗前2组梗死灶面积比较差异无统计学意义(P>0.05);经治疗后,2组梗死灶面积均有所改善,其中观察组治疗12个月后大面积、小面积梗死灶分别减少3例和7例(改善率41.2%);对照组治疗12个月后大面积、小面积梗死灶分别减少1例和4例(改善率22.2%),但2组治疗后3、6、12个月脑梗死面积改善情况差异均无统计学意义(P>0.05)。结论:瑞舒伐他汀能明显改善脑梗死患者的血脂及神经功能,不良反应少,对改善脑梗死临床预后具有重要意义。Abstract: Objective: To explore the effect of rosuvastatin on the blood lipid and neurofunctional of patients with arteriosclerotic cerebral infarction.Methods: Sixty-two patients with cerebral infarction were divided into observation group and control group by a prospective randomized open method.Conventional therapy such as anticoagulants,dehydrating agent and drugs to improve the microcirculation was applied to all the patients;and the patients in the observation group were administered statin rosuvastatin calcium tablets in addition to the routine therapy.The blood lipid,nerve function,carotid intima - media thickness(IMT) and the infarct size were compared between the two groups before treatment,3,6 and 12 months after treatment.Results: Compared with the control group,the TC,TG and LDL of the observation group decreased(P<0.01),the HDL increased(P<0.01),the IMT diminished(P<0.01) and the nerve function improved significantly after 12 months of treatment(P<0.01).Before treatment,the infarct area had no significant difference between the two groups(P>0.05);after treatment,the infarct area in the two groups diminished significantly.After 12 months of therapy,3 cases of large area of infarct and 7 cases of small area of infarct in the observation group improved(41.2%),and 1 case of large area of infarct and 4 cases of mall area of infarct in the control group improved(22.2%).The difference in the infarct area was not statistically significant after treatment for 3 months,6 months or 12 months(P>0.05).Conclusions: Rosuvastatin can significantly improve the cerebral blood lipid and nerve function,decrease the adverse reactions and improve the clinical outcome of patients with cerebral infarction.
-
Key words:
- infarction /
- rosuvastatin /
- lipids /
- neurological
-
[1] Curtis PJ,Potter J,Kroon PA,et al.Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes:a double-blind randomized controlled trial [J].Am J Clin Nutr,2013,97(5):936-942. [2] Neary NM,Booker OJ,Abel BS,et al.Hypercortisolism is associated with increased coronary arterial atherosclerosis:analysis of noninvasive coronary angiography using multidetector computerized tomography [J].J Clin Endocrinol Metab,2013,98(5):2045-2052. [3] 彭艳,邓中云,冯文兵.辛伐他汀联合阿司匹林对伴有颈动脉粥样硬化的脑梗死复发的影响[J].蚌埠医学院学报,2012,37(6):696-698. [4] 刘慧华,王军.脑梗死患者颈动脉粥样硬化与尿白蛋白关系的研究[J].蚌埠医学院学报,2012,37(2):176-178. [5] Lamas GA,Goertz C,Boineau R,et al.Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction:the TACT randomized trial [J].JAMA,2013,309(12):1241-1250. [6] Araki Y,Kumakura H,Kanai H,et al.Prevalence and risk factors for cerebral infarction and carotid artery stenosis in peripheral arterial disease [J].Atherosclerosis,2012,223(2):473-477. [7] Zhou Q,Ruan ZR,Yuan H,et al.ABCB1 gene polymorphisms,ABCB1 haplotypes and ABCG2 c.421c >A are determinants of inter-subject variability in rosuvastatin pharmacokinetics [J].Pharmazie,2013,68(2):129-134. [8] 王杰,严云燕,戴光明.大面积脑梗死后出血性转化相关危险因素的临床研究[J].齐齐哈尔医学院学报,2013,34(8):1112-1114. [9] 郝茹,张涛.神经节苷脂联合依达拉奉对急性脑梗死患者神经功能及血液流变学的影响[J].中国医药导报,2012,9(29):103-105. [10] Iida O,Soga Y,Yamauchi Y,et al.Clinical efficacy of endovascular therapy for patients with critical limb ischemia attributable to pure isolated infrapopliteal lesions[J].J Vasc Surg,2013,57(4):974-981. [11] Marioni RE,Stewart MC,Murray GD,et al.Peripheral levels of fibrinogen,C-reactive protein,and plasma viscosity predict future cognitive decline in individuals without dementia[J].Psychosom Med,2009,71(8):901-906. [12] 钟钧琳,彭隆,罗艳婷,等.瑞舒伐他汀抑制C-反应蛋白诱导的晚期内皮祖细胞炎症因子的表达[J].中国病理生理杂志,2013,29(4):597-602. [13] 印荻,章旭,曹娟,等.瑞舒伐他汀治疗慢性肾脏病晚期颈动脉粥样斑块的临床研究[J].安徽医药,2012,16(3):365-367. [14] Sánchez-Aguilar M,Tapia-Pérez JH,Sánchez-Rodríguez JJ,et al.Effect of rosuvastatin on cytokines after traumatic head injury[J].J Neurosurg,2013,118(3):669-675. [15] Ballantyne CM,Pitt B,Loscalzo J,et al.Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome(from the Limiting UN dertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial)[J].Am J Cardiol,2013,111(4):506-509. -
点击查看大图
计量
- 文章访问数: 3578
- HTML全文浏览量: 374
- PDF下载量: 4
- 被引次数: 0
下载:
